查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1195563

活动记录传感器和多导睡眠图设备市场 - 增长、趋势、COVID-19 影响和预测 (2023-2028)

Actigraphy Sensors and Polysomnography Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

活动记录仪传感器和多导睡眠图设备市场预计在预测期内的复合年增长率为 5.5%。

COVID-19 大流行导致最近护理服务发生变化，远程医疗、远程测试、数据监控、消费级戒指、手錶、眼带或头带以及其他可穿戴设备中的脉搏血氧仪的扩展。加速了消费者对诸如使用 EEG 传感器自我监测生理数据、AI/ML/DL 集成（例如具有心率变异性 (HRV) 的产品）等产品，以及催化睡眠医学领域的快速技术颠覆。 随着远程医疗的扩展，医生和患者对远程诊断和数据监控技术越来越感兴趣，在大流行的背景下，一次性家用睡眠呼吸暂停检测设备的使用也在增加。就是一个例子。 例如，2021 年 1 月，国际环境研究与公共卫生杂誌报导称，人工智能情绪分析工具 Valence Aware Dictionary 和 sEntiment Reasoner (VADER) 有效地调查了孕妇在 COVID-19 期间发布的推文以减少焦虑。 19 大流行。，发表了一篇文章，指出他们发现与抑郁、睡眠问题和孤立有关的痛苦。 美国睡眠协会 (AASM) 于 2022 年 4 月发布的技术报告指出，全球终端用户在可穿戴腕带和智能手錶设备上的支出从 2021 年到 2022 年将增长 16.6%，从 2020 年到 2021 年将增长 16.6%。预计将增加14.6%。

人口老龄化增加，失眠、不宁腿综合征、睡眠相关呼吸障碍、发作性睡病和嗜睡症等慢性睡眠障碍的发病率上升，尤其是在成人中；预计有几个因素将推动市场增长，例如增加研究和为进步而发展。 国家医学图书馆 2021 年发表的研究表明，阻塞性睡眠呼吸暂停 (OSA) 影响 2-9% 的成年人，不宁腿综合征影响 5-10% 的成年人和 2-4 % 的儿童，估计发作性睡病每年影响美国 135,000 至 200,000 人。

因此，现在大多数治疗方案都将活动记录仪传感器或多导睡眠监测仪纳入临床治疗计划。 此外，市场参与者的新产品发布和技术进步正在对所研究市场的增长产生积极影响。 例如，2022 年 11 月，Nature and Science of Sleep 发表的一项研究表明，OSAnet 这种新颖的深度学习技术可用于检测和识别家用设备中的阻塞性睡眠呼吸暂停。我来了。 该算法基于使用非接触式录音机记录的睡眠声音，可用于 OSA 评估和筛查。

因此，由于上述因素（例如采用先进的数字技术、远程睡眠技术、睡眠相关疾病的增加以及最新的产品发布），预计所研究的市场在研究期间将显着增长. 然而，与活动记录传感器和多导睡眠监测设备的製造策略相关的严格监管框架和标准预计将阻碍研究期间的市场增长。

活动记录仪传感器和多导睡眠图的市场趋势

预计无线技术在预测期内将占很大份额

  • 预计市场将由无线技术领域主导。 预计需求将在很大程度上受到新产品的技术能力、易用性、实时提供结果的能力、进行高灵敏度测试的能力以及有助于疾病诊断的无线技术的持续技术改进的推动。因为 此外，由于新兴国家医疗保健系统越来越多地采用无线医疗设备和诊断工具，活动记录传感器和多导睡眠图设备市场将提供有吸引力的销售。
  • 活动记录仪传感器和多导睡眠图设备的市场製造商正在整合无线技术等下一代技术，以提高其产品的准确性和可靠性，最终在活动记录仪传感器和多导睡眠图设备市场占据一席之地。我们的目标是保持我们的位置。 此外，市场主要参与者持续推出的产品对该细分市场的增长产生了积极影响。 例如，2022 年 9 月，亚马逊宣布推出新系列睡眠追踪产品 The Halo Rise，该产品使用非接触式传感器将您的运动和呼吸模式与您的睡眠质量和表现相匹配，以检测状态。 AASM 的睡眠医学人工智能委员会在 2022 年 4 月还指出，光电体积描记技术在智能手錶和健身追踪器中的普遍使用可能有助于大规模诊断阻塞性睡眠呼吸暂停。据报导，事实并非如此。
  • 因此，下一代活动记录仪传感器和多导睡眠监测仪的推出以及大多数製造商对将无线技术融入其产品的关注将有助于该细分市场在未来几年的增长。

活动记录仪传感器和多导睡眠图市场预计将由北美主导

  • 预计在未来五年内，北美将在全球活动记录传感器和多导睡眠监测设备市场中占据很大份额。 增长的主要驱动力是老年人口的增加、慢性睡眠障碍的高患病率、技术突破带来的行业效率和可负担性，以及成熟研究机构的存在。
  • 在 COVID-19 期间，为支持患有睡眠障碍的老年患者而对这些设备的需求不断增长，预期寿命的持续延长正在推动该地区研究市场的增长。被认为会促进
  • 根据 2022 年 7 月美国医学协会 VA/DOH 健康服务中心的数据，多达 66% 的人在一生中的某个时刻会说梦话 据估计，超过 40% 的美国人还患有精神疾病。 因此，对评估睡眠相关障碍的设备的需求正在增加，预计这将推动该地区活动记录传感器和多导睡眠监测仪的增长。
  • 此外，由于消费者对产品的需求与产品可用性直接相关，因此市场份额更大，因此主要设备製造商正在加强其在美国的分销和供应网络。 例如，2021 年 2 月，FDA 在美国批准了一种新的处方设备，用于缓解打鼾和轻度阻塞性睡眠呼吸暂停。 eXciteOSA 由 Signifier Medical Technologies 开发，是第一款通过咬嘴向清醒的舌头提供神经肌肉刺激治疗的设备。 2022 年 8 月，AASM 将启动一项名为 AI/Autoscoring Certification Program 的为期两年的试点项目，以客观验证这些自动评分系统的有效性。计划启动。

活动记录传感器和多导睡眠图设备市场的竞争对手分析

活动记录仪传感器和多导睡眠图设备市场具有一定的整合性和竞争性，由几家大型企业组成。 目前主导活动记录传感器和多导睡眠图设备市场的公司包括 ActiGraph LLC、Activinsights Ltd、Aetna Inc、BMC Medical、Cidelec、Cleveland Medical Devices Inc、Compumedics Ltd、Fitbit Inc、Garmin Ltd、iHealth Labs Inc.、Koninklijke Philips NV、Natus Medical公司、Nox Medical、ResMed Inc、SOMNOmedics GmbH。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动因素
    • 慢性病和神经系统疾病的患病率上升
    • 失眠治疗的需求增加和投资增加
    • 智能 Actig 传感器和先进技术的进步，以提高 PSG 设备的可访问性
  • 市场製约因素
    • 製造策略的标准和严格的监管框架
  • 行业吸引力 - 波特五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（价值基础，市场规模：100 万美元）

  • 按产品类型
    • 活动记录仪传感器
      • 手腕/手带式活动计
      • 可穿戴活动记录仪
    • 多导睡眠图设备
      • 固定式多导睡眠监测仪
      • 便携式多导睡眠图
  • 按技术类型
    • USB
    • 无线技术
    • 全球定位系统
    • 其他
  • 按销售渠道
    • 医院
    • 药房
    • 诊断机构
    • 其他
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • ActiGraph LLC
    • Activinsights Ltd
    • Aetna Inc.
    • BMC Medical Co. Ltd
    • Cidelec
    • Cleveland Medical Devices Inc.
    • Compumedics Ltd
    • Fitbit LLC
    • Garmin Ltd
    • iHealth Labs Inc.
    • Koninklijke Philips NV
    • Nox Medical
    • ResMed Inc.
    • SOMNOmedics GmbH

第7章 市场机会与今后动向

简介目录
Product Code: 93108

The actigraphy sensors and polysomnography devices market is expected to register a CAGR of 5.5% over the forecast period.

The COVID-19 pandemic has catalyzed rapid technologic disruption in sleep medicine by accelerating consumer demand for products, including recent care delivery changes, telehealth expansion, remote testing, data monitoring, self-monitoring physiological data using pulse oximeters or EEG sensors in consumer-grade rings, watches, eye or headbands, and other wearables, and AI/ML/DL integrations such as those using heart rate variability (HRV). As telemedicine expands, both physicians and patients are becoming more interested in remote diagnostic and data monitoring technology, including the increased use of disposable home sleep apnea testing devices in the context of the pandemic. For instance, the International Journal of Environmental Research and Public Health published an article in January 2021 where the Valence Aware Dictionary and sEntiment Reasoner (VADER), an AI sentiment analysis tool, was enabled for the examination of tweets from pregnant women and discovered anxiety, depressive symptoms, sleep issues, and anguish connected to isolation during the COVID-19 pandemic. The American Academy of Sleep Medicine (AASM)'s Technology Report published in April 2022 projected a 16.6% growth in end-user spending on wearable wristbands and smartwatch devices worldwide between 2021 and 2022 and a 14.6% rise between 2020 and 2021.

Several factors, such as a rise in the geriatric population, the rising incidence of sleep disorders such as insomnia, restless leg syndrome, sleep-related breathing disorders, and chronic sleep disorders like narcolepsy and hypersomnia, especially among adults, and an increase in the research and development for technological advancements in terms of sleep disease diagnostics and management is projected to drive the growth of the market. Several studies published by the National Library of Medicine in 2021 estimated obstructive sleep apnea (OSA) affects 2-9% of the adult population, restless leg syndrome affects 5-10% of adults and 2-4% of children, and narcolepsy affects between 135,000 and 200,000 people in the United States annually.

As a result, most treatment regimens now incorporate actigraphy sensors and polysomnography devices into their clinical treatment plans. In addition, new product launches and technological advancements by major players in the market are positively affecting the growth of the studied market. For instance, the Nature and Science of Sleep published a research in November 2022 stating that the novel deep-learning technique, OSAnet, could be feasible for the detection and identification of obstructive sleep apnea in home-based devices. The algorithm is based on sleep sounds recorded by a non-contact voice recorder that can be used for the assessment and screening of OSA.

Therefore, owing to the aforementioned factors, such as the adoption of advancing digital technologies, remote sleep technologies, and rising sleep-related disorders coupled with the latest product launches, the studied market is expected to grow significantly during the study period. However, stringent regulatory frameworks and standards associated with manufacturing strategies for actigraphy sensors and polysomnography devices are expected to hinder the growth of the market during the study period.

Actigraphy Sensors & Polysomnography Devices Market Trends

Wireless Technology is Expected to Hold Significant Share Over the Forecast Period

  • The market is predicted to be dominated by the wireless technology segment since demand is anticipated to be driven by the majority of new products' technological capabilities, user-friendliness, ability to deliver real-time results, capacity for highly sensitive tests, and ongoing technical improvement in wireless technologies, that are helpful in disease diagnosis. Furthermore, the market for actigraphy sensors and polysomnography devices is to see attractive sales prospects due to the growing adoption of wireless medical equipment and diagnostic tools in the healthcare system of developing countries.
  • The manufacturers in the actigraphy sensors and polysomnography devices market are integrating next-generation technologies, such as wireless technologies, in order to increase the accuracy and reliability of their products and ultimately to maintain a strong position in the actigraphy sensors and polysomnography devices market. Furthermore, continuous product launches by major players in the market are positively affecting the growth of the segment. For instance, in September 2022, Amazon announced the launch of a new sleep tracking product to the line, The Halo Rise, which uses contactless sensors to detect sleep quality and states, coupled with movements and breathing patterns. In addition, the Artificial Intelligence in Sleep Medicine Committee of AASM in April 2022 reported that the ubiquitous availability of Photoplethysmography technology in smartwatches and fitness trackers might allow for obstructive sleep apnea diagnosis at scale.
  • Thus, the launch of the next-generation actigraphy sensor and polysomnography devices, as well as the majority of manufacturers focusing on deploying wireless technology in their products, are expected to contribute to the segment's growth over the coming years.

North America is Expected to Dominate the Actigraphy Sensors and Polysomnography Devices Market

  • North America is expected to hold a significant share of the global actigraphy sensors and polysomnography devices market during the next five years. The major factors attributing to the growth are the rising geriatric population, the high prevalence of chronic sleep disorders, the efficiency and affordability of the industry with the technological breakthroughs, as well as the presence of established research institutions.
  • The rising demand for these devices during COVID-19 to support geriatric patients who experience sleep difficulties, as well as the fact that life expectancy is continuing to increase, is likely to drive the growth of the studied market in this region.
  • According to the Department of Veterans Affairs/Department of Defense Health Affairs, the American College of Physicians, and the AASM conclusion in July 2022, up to 66% of people talk in their sleep at some point in their lives, and more than 40% of people with insomnia are believed to also be affected by a mental health disorder in the United States. This increases the demand for devices used to evaluate sleep-related disorders and is expected to drive the growth of actigraphy sensors and polysomnography devices in the region.
  • Additionally, the major device manufacturers have been bolstering their distribution and supply chains in the United States since consumer demand for a product is directly correlated with its availability, which results in a bigger market share. For instance, in February 2021, the FDA authorized the marketing of a new prescription device to reduce snoring and mild obstructive sleep apnea in the United States. The eXciteOSA, developed by Signifier Medical Technologies, is the first device that uses neuromuscular stimulation therapy on the tongue while awake through a mouthpiece. In August 2022, AASM launched a two-year pilot program called the AI/Autoscoring Certification Program in order to objectively validate the effectiveness of these auto-scoring systems, which will start accepting applications in early 2023 for polysomnograms for sleep stage scoring.

Actigraphy Sensors & Polysomnography Devices Market Competitor Analysis

The actigraphy sensors and polysomnography devices market is moderately consolidated and competitive and consists of several major players. Some of the companies that are currently dominating the actigraphy sensors and polysomnography devices market are ActiGraph LLC, Activinsights Ltd, Aetna Inc., BMC Medical Co. Ltd, Cidelec, Cleveland Medical Devices Inc., Compumedics Ltd, Fitbit Inc., Garmin Ltd, iHealth Labs Inc., Koninklijke Philips NV, Natus Medical Inc., Nox Medical, ResMed Inc., and SOMNOmedics GmbH, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic Diseases and Neurological Disorders
    • 4.2.2 Rise in Demand for Insomnia Treatment and Growing Investments
    • 4.2.3 Emergence of Advanced Technologies to Increase Accessibility of Smart Actigraphy Sensor and PSG Devices
  • 4.3 Market Restraints
    • 4.3.1 Standards and Stringent Regulatory Framework for Manufacturing Strategies
  • 4.4 Industry Attractiveness - Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Actigraphy Sensors
      • 5.1.1.1 Wrist and Handband Actigraphy Products
      • 5.1.1.2 Wearable Actigraphy Products
    • 5.1.2 Polysomnography Devices
      • 5.1.2.1 Fixed Polysomnography Products
      • 5.1.2.2 Portable Polysomnography Products
  • 5.2 By Technology Type
    • 5.2.1 USB
    • 5.2.2 Wireless Technology
    • 5.2.3 GPS
    • 5.2.4 Others
  • 5.3 By Distribution Channel
    • 5.3.1 Hospitals
    • 5.3.2 Pharmacies
    • 5.3.3 Diagnostic Laboratories
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ActiGraph LLC
    • 6.1.2 Activinsights Ltd
    • 6.1.3 Aetna Inc.
    • 6.1.4 BMC Medical Co. Ltd
    • 6.1.5 Cidelec
    • 6.1.6 Cleveland Medical Devices Inc.
    • 6.1.7 Compumedics Ltd
    • 6.1.8 Fitbit LLC
    • 6.1.9 Garmin Ltd
    • 6.1.10 iHealth Labs Inc.
    • 6.1.11 Koninklijke Philips NV
    • 6.1.12 Nox Medical
    • 6.1.13 ResMed Inc.
    • 6.1.14 SOMNOmedics GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS